What is Asgn Inc's earnings per share (EPS)?

Asgn Inc (ASGN) reported diluted earnings per share of $2.60 for fiscal year 2025. This represents a -32.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Asgn Inc Financials

ASGN

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Asgn Inc (ASGN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 43/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Asgn Inc has an operating margin of 5.8%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 35/100, indicating healthy but not exceptional operating efficiency. This is down from 7.4% the prior year.

Growth

Asgn Inc's revenue declined 2.9% year-over-year, from $4.1B to $4.0B. This contraction results in a growth score of 28/100.

Leverage

Asgn Inc carries a low D/E ratio of 0.65, meaning only $0.65 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Asgn Inc's current ratio of 2.16 indicates adequate short-term liquidity, earning a score of 40/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Asgn Inc has a free cash flow margin of 7.2%, earning a moderate score of 43/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Asgn Inc generates a 6.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 25/100. This is down from 9.9% the prior year.

Altman Z-Score Grey Zone

2.38

Asgn Inc scores 2.38, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

4/9

Asgn Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.89x

For every $1 of reported earnings, Asgn Inc generates $2.89 in operating cash flow ($327.9M OCF vs $113.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.4x

Asgn Inc earns $3.4 in operating income for every $1 of interest expense ($230.3M vs $67.7M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.0B

YoY-2.9%

5Y CAGR+2.6%

10Y CAGR+6.8%

Asgn Inc generated $4.0B in revenue in fiscal year 2025. This represents a decrease of 2.9% from the prior year.

EBITDA

$343.8M

YoY-14.2%

5Y CAGR-1.5%

10Y CAGR+5.4%

Asgn Inc's EBITDA was $343.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 14.2% from the prior year.

Net Income

$113.5M

YoY-35.2%

5Y CAGR-10.7%

10Y CAGR+1.5%

Asgn Inc reported $113.5M in net income in fiscal year 2025. This represents a decrease of 35.2% from the prior year.

EPS (Diluted)

$2.60

YoY-32.1%

5Y CAGR-7.1%

10Y CAGR+3.5%

Asgn Inc earned $2.60 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 32.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$288.1M

YoY-21.0%

5Y CAGR-6.0%

10Y CAGR+11.2%

Asgn Inc generated $288.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 21.0% from the prior year.

Cash & Debt

$161.2M

YoY-21.4%

5Y CAGR-10.1%

10Y CAGR+21.0%

Asgn Inc held $161.2M in cash against $1.2B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

41M

YoY-5.3%

5Y CAGR-4.8%

10Y CAGR-2.5%

Asgn Inc had 41M shares outstanding in fiscal year 2025. This represents a decrease of 5.3% from the prior year.

Margins & Returns

Gross Margin

28.9%

YoY+0.0pp

5Y CAGR+1.8pp

10Y CAGR-4.0pp

Asgn Inc's gross margin was 28.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.0 percentage points from the prior year.

Operating Margin

5.8%

YoY-1.6pp

5Y CAGR-2.2pp

10Y CAGR-1.6pp

Asgn Inc's operating margin was 5.8% in fiscal year 2025, reflecting core business profitability. This is down 1.6 percentage points from the prior year.

Net Margin

2.9%

YoY-1.4pp

5Y CAGR-2.9pp

10Y CAGR-1.9pp

Asgn Inc's net profit margin was 2.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.4 percentage points from the prior year.

Return on Equity

6.3%

YoY-3.6pp

5Y CAGR-6.3pp

10Y CAGR-6.2pp

Asgn Inc's ROE was 6.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$170.1M

YoY-48.0%

5Y CAGR+43.6%

10Y CAGR+59.0%

Asgn Inc spent $170.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 48.0% from the prior year.

Capital Expenditures

$39.8M

YoY+12.7%

5Y CAGR+4.1%

10Y CAGR+4.9%

Asgn Inc invested $39.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 12.7% from the prior year.

ASGN Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$4.0B-2.9%	$4.1B-7.9%	$4.5B-2.8%	$4.6B+14.3%	$4.0B+14.5%	$3.5B
Cost of Revenue	$2.8B-2.9%	$2.9B-8.0%	$3.2B-1.3%	$3.2B+12.0%	$2.9B+12.2%	$2.6B
Gross Profit	$1.1B-2.9%	$1.2B-7.5%	$1.3B-6.5%	$1.4B+19.9%	$1.1B+20.6%	$947.2M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$854.0M+4.0%	$821.2M-2.7%	$844.2M-5.7%	$895.0M+21.6%	$735.8M+19.6%	$615.0M
Operating Income	$230.3M-24.3%	$304.4M-16.4%	$364.1M-11.1%	$409.5M+16.7%	$350.9M+24.8%	$281.2M
Interest Expense	$67.7M+5.3%	$64.3M-3.2%	$66.4M+44.7%	$45.9M+22.4%	$37.5M-5.5%	$39.7M
Income Tax	$49.1M-24.3%	$64.9M-17.2%	$78.4M-18.9%	$96.7M+18.5%	$81.6M+27.7%	$63.9M
Net Income	$113.5M-35.2%	$175.2M-20.1%	$219.3M-18.2%	$268.1M-34.6%	$409.9M+104.6%	$200.3M
EPS (Diluted)	$2.60-32.1%	$3.83-14.9%	$4.50-14.0%	$5.23-31.7%	$7.66+103.7%	$3.76

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$980.1M-3.1%	$1.0B-0.9%	$1.0B+5.4%	$968.3M-1.7%	$985.0M-4.5%	$1.0B-0.4%	$1.0B-1.4%	$1.0B
Cost of Revenue	$696.6M-2.5%	$714.5M-1.8%	$727.3M+5.0%	$692.9M-0.9%	$699.0M-4.3%	$730.6M-0.4%	$733.6M-2.6%	$752.8M
Gross Profit	$283.5M-4.5%	$296.9M+1.2%	$293.3M+6.5%	$275.4M-3.7%	$286.0M-4.8%	$300.4M-0.2%	$301.1M+1.7%	$296.2M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$210.5M-0.8%	$212.2M-2.1%	$216.8M+1.1%	$214.5M+8.4%	$197.9M-4.6%	$207.5M+0.9%	$205.6M-2.2%	$210.2M
Operating Income	$56.2M-17.2%	$67.9M+13.9%	$59.6M+27.9%	$46.6M-37.2%	$74.2M-6.0%	$78.9M-1.9%	$80.4M+13.4%	$70.9M
Interest Expense	$16.7M-4.0%	$17.4M-4.4%	$18.2M+18.2%	$15.4M+3.4%	$14.9M-6.9%	$16.0M+1.3%	$15.8M-10.2%	$17.6M
Income Tax	$14.3M+15.3%	$12.4M+2.5%	$12.1M+17.5%	$10.3M-39.1%	$16.9M+9.7%	$15.4M-11.5%	$17.4M+14.5%	$15.2M
Net Income	$25.2M-33.9%	$38.1M+30.0%	$29.3M+40.2%	$20.9M-50.7%	$42.4M-10.7%	$47.5M+0.6%	$47.2M+23.9%	$38.1M
EPS (Diluted)	N/A	$0.87+29.9%	$0.67+39.6%	$0.48	N/A	$1.06+3.9%	$1.02+25.9%	$0.81

ASGN Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.7B+7.2%	$3.4B-3.3%	$3.5B-1.1%	$3.6B+2.4%	$3.5B+6.9%	$3.3B
Current Assets	$916.2M-0.2%	$917.7M-5.7%	$973.3M-0.8%	$981.1M-25.1%	$1.3B+31.7%	$994.4M
Cash & Equivalents	$161.2M-21.4%	$205.2M+16.7%	$175.9M+150.2%	$70.3M-86.7%	$529.6M+93.0%	$274.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$674.4M+3.6%	$650.8M-12.2%	$741.5M-13.1%	$853.6M+20.5%	$708.2M+17.5%	$602.8M
Goodwill	$2.1B+13.2%	$1.9B-0.1%	$1.9B+0.1%	$1.9B+20.5%	$1.6B+10.5%	$1.4B
Total Liabilities	$1.9B+13.4%	$1.7B0.0%	$1.7B-1.9%	$1.7B+2.9%	$1.6B-3.2%	$1.7B
Current Liabilities	$424.3M+15.6%	$367.1M-6.9%	$394.1M-10.8%	$441.9M-2.0%	$450.9M+8.3%	$416.2M
Long-Term Debt	$1.2B+13.1%	$1.0B-0.3%	$1.0B-2.8%	$1.1B+3.2%	$1.0B0.0%	$1.0B
Total Equity	$1.8B+1.5%	$1.8B-6.1%	$1.9B-0.5%	$1.9B+1.9%	$1.9B+17.5%	$1.6B
Retained Earnings	$1.1B-0.5%	$1.1B-8.2%	$1.2B-0.4%	$1.2B+2.2%	$1.2B+26.8%	$926.3M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$3.7B-0.6%	$3.7B-0.4%	$3.7B+0.4%	$3.7B+7.9%	$3.4B-0.1%	$3.4B-0.6%	$3.5B-1.1%	$3.5B
Current Assets	$916.2M-0.2%	$918.4M+0.2%	$916.3M+4.2%	$879.6M-4.2%	$917.7M+1.1%	$907.3M-0.7%	$913.9M-2.1%	$933.4M
Cash & Equivalents	$161.2M+27.4%	$126.5M-8.9%	$138.9M+29.8%	$107.0M-47.9%	$205.2M+23.2%	$166.6M+26.0%	$132.2M-16.5%	$158.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$674.4M-5.1%	$710.4M+2.8%	$691.3M-2.0%	$705.3M+8.4%	$650.8M-5.2%	$686.4M-4.9%	$721.4M-0.5%	$725.3M
Goodwill	$2.1B0.0%	$2.1B+0.1%	$2.1B+0.1%	$2.1B+13.0%	$1.9B-0.1%	$1.9B0.0%	$1.9B0.0%	$1.9B
Total Liabilities	$1.9B+0.3%	$1.9B-1.1%	$1.9B-0.9%	$1.9B+15.3%	$1.7B-0.3%	$1.7B+0.9%	$1.6B+1.0%	$1.6B
Current Liabilities	$424.3M-8.2%	$462.3M+6.4%	$434.6M+17.0%	$371.5M+1.2%	$367.1M-9.0%	$403.6M+3.5%	$390.1M+5.0%	$371.7M
Long-Term Debt	$1.2B+0.3%	$1.2B-3.8%	$1.2B-5.5%	$1.3B+24.1%	$1.0B-0.1%	$1.0B-0.1%	$1.0B-0.1%	$1.0B
Total Equity	$1.8B-1.6%	$1.8B+0.3%	$1.8B+1.9%	$1.8B+0.9%	$1.8B+0.1%	$1.8B-1.9%	$1.8B-2.9%	$1.9B
Retained Earnings	$1.1B-1.4%	$1.1B+0.6%	$1.1B+2.1%	$1.1B-1.7%	$1.1B+0.5%	$1.1B-2.8%	$1.1B-3.7%	$1.2B

ASGN Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$327.9M-18.0%	$400.0M-12.5%	$456.9M+48.4%	$307.8M+58.9%	$193.7M-54.4%	$424.8M
Capital Expenditures	$39.8M+12.7%	$35.3M-11.5%	$39.9M+6.4%	$37.5M+8.1%	$34.7M+6.4%	$32.6M
Free Cash Flow	$288.1M-21.0%	$364.7M-12.5%	$417.0M+54.3%	$270.3M+70.0%	$159.0M-59.5%	$392.2M
Investing Cash Flow	-$343.9M-874.2%	-$35.3M+12.8%	-$40.5M+92.1%	-$510.0M-306.9%	$246.5M+212.6%	-$219.0M
Financing Cash Flow	-$29.4M+91.2%	-$333.2M-7.2%	-$310.9M-21.2%	-$256.5M-39.1%	-$184.4M-535.9%	-$29.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$170.1M-48.0%	$327.2M+19.8%	$273.1M-2.9%	$281.4M+55.2%	$181.3M+549.8%	$27.9M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$102.3M+21.9%	$83.9M-32.8%	$124.9M+643.5%	$16.8M-83.2%	$100.2M-26.2%	$135.8M+49.7%	$90.7M+23.7%	$73.3M
Capital Expenditures	$8.6M-27.7%	$11.9M+30.8%	$9.1M-10.8%	$10.2M-9.7%	$11.3M+43.0%	$7.9M+49.1%	$5.3M-50.9%	$10.8M
Free Cash Flow	$93.7M+30.1%	$72.0M-37.8%	$115.8M+1654.5%	$6.6M-92.6%	$88.9M-30.5%	$127.9M+49.8%	$85.4M+36.6%	$62.5M
Investing Cash Flow	-$6.6M+44.5%	-$11.9M-30.8%	-$9.1M+97.1%	-$316.3M-2699.1%	-$11.3M-41.3%	-$8.0M-53.8%	-$5.2M+51.9%	-$10.8M
Financing Cash Flow	-$61.2M+27.6%	-$84.5M+0.5%	-$84.9M-142.2%	$201.2M+505.6%	-$49.6M+46.6%	-$92.9M+16.1%	-$110.7M-38.4%	-$80.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$64.2M+39.6%	$46.0M+384.2%	$9.5M-81.2%	$50.4M+14.8%	$43.9M-54.1%	$95.6M-11.5%	$108.0M+35.5%	$79.7M

ASGN Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	28.9%0.0pp	28.9%+0.1pp	28.8%-1.1pp	29.9%+1.4pp	28.5%+1.4pp	27.1%
Operating Margin	5.8%-1.6pp	7.4%-0.8pp	8.2%-0.8pp	8.9%+0.2pp	8.8%+0.7pp	8.0%
Net Margin	2.9%-1.4pp	4.3%-0.7pp	4.9%-0.9pp	5.9%-4.4pp	10.2%+4.5pp	5.7%
Return on Equity	6.3%-3.6pp	9.9%-1.7pp	11.6%-2.5pp	14.1%-7.9pp	22.0%+9.3pp	12.6%
Return on Assets	3.1%-2.0pp	5.1%-1.1pp	6.2%-1.3pp	7.5%-4.2pp	11.7%+5.6pp	6.1%
Current Ratio	2.16-0.3	2.50+0.0	2.47+0.2	2.22-0.7	2.90+0.5	2.39
Debt-to-Equity	0.65+0.1	0.58+0.0	0.55-0.0	0.560.0	0.55-0.1	0.65
FCF Margin	7.2%-1.7pp	8.9%-0.5pp	9.4%+3.5pp	5.9%+1.9pp	4.0%-7.2pp	11.2%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	28.9%-0.4pp	29.4%+0.6pp	28.7%+0.3pp	28.4%-0.6pp	29.0%-0.1pp	29.1%+0.0pp	29.1%+0.9pp	28.2%
Operating Margin	5.7%-1.0pp	6.7%+0.9pp	5.8%+1.0pp	4.8%-2.7pp	7.5%-0.1pp	7.6%-0.1pp	7.8%+1.0pp	6.8%
Net Margin	2.6%-1.2pp	3.8%+0.9pp	2.9%+0.7pp	2.2%-2.1pp	4.3%-0.3pp	4.6%+0.1pp	4.6%+0.9pp	3.6%
Return on Equity	1.4%-0.7pp	2.1%+0.5pp	1.6%+0.4pp	1.2%-1.2pp	2.4%-0.3pp	2.7%+0.1pp	2.6%+0.6pp	2.1%
Return on Assets	0.7%-0.3pp	1.0%+0.2pp	0.8%+0.2pp	0.6%-0.7pp	1.2%-0.1pp	1.4%0.0pp	1.4%+0.3pp	1.1%
Current Ratio	2.16+0.2	1.99-0.1	2.11-0.3	2.37-0.1	2.50+0.3	2.25-0.1	2.34-0.2	2.51
Debt-to-Equity	0.65+0.0	0.64-0.0	0.66-0.1	0.72+0.1	0.580.0	0.58+0.0	0.57+0.0	0.56
FCF Margin	9.6%+2.4pp	7.1%-4.2pp	11.3%+10.7pp	0.7%-8.3pp	9.0%-3.4pp	12.4%+4.2pp	8.3%+2.3pp	6.0%

Similar Companies

Dxc Technology DXC

$2.1B

Globant S A GLOB

$2.1B

VNET GROUP INC VNET

$2.2B

Formula Systems FORTY

$1.9B

Wns Hldgs WNS

$3.3B

Frequently Asked Questions

What is Asgn Inc's annual revenue?

Asgn Inc (ASGN) reported $4.0B in total revenue for fiscal year 2025. This represents a -2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Asgn Inc's revenue growing?

Asgn Inc (ASGN) revenue declined by 2.9% year-over-year, from $4.1B to $4.0B in fiscal year 2025.

Is Asgn Inc profitable?

Yes, Asgn Inc (ASGN) reported a net income of $113.5M in fiscal year 2025, with a net profit margin of 2.9%.

What is Asgn Inc's EBITDA?

Asgn Inc (ASGN) had EBITDA of $343.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Asgn Inc have?

As of fiscal year 2025, Asgn Inc (ASGN) had $161.2M in cash and equivalents against $1.2B in long-term debt.

What is Asgn Inc's gross margin?

Asgn Inc (ASGN) had a gross margin of 28.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Asgn Inc's operating margin?

Asgn Inc (ASGN) had an operating margin of 5.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Asgn Inc's net profit margin?

Asgn Inc (ASGN) had a net profit margin of 2.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Asgn Inc's return on equity (ROE)?

Asgn Inc (ASGN) has a return on equity of 6.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Asgn Inc's free cash flow?

Asgn Inc (ASGN) generated $288.1M in free cash flow during fiscal year 2025. This represents a -21.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Asgn Inc's operating cash flow?

Asgn Inc (ASGN) generated $327.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Asgn Inc's total assets?

Asgn Inc (ASGN) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Asgn Inc's capital expenditures?

Asgn Inc (ASGN) invested $39.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Asgn Inc buy back shares?

Yes, Asgn Inc (ASGN) spent $170.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Asgn Inc have outstanding?

Asgn Inc (ASGN) had 41M shares outstanding as of fiscal year 2025.

What is Asgn Inc's current ratio?

Asgn Inc (ASGN) had a current ratio of 2.16 as of fiscal year 2025, which is generally considered healthy.

What is Asgn Inc's debt-to-equity ratio?

Asgn Inc (ASGN) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Asgn Inc's return on assets (ROA)?

Asgn Inc (ASGN) had a return on assets of 3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Asgn Inc's Altman Z-Score?

Asgn Inc (ASGN) has an Altman Z-Score of 2.38, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Asgn Inc's Piotroski F-Score?

Asgn Inc (ASGN) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Asgn Inc's earnings high quality?

Asgn Inc (ASGN) has an earnings quality ratio of 2.89x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Asgn Inc cover its interest payments?

Asgn Inc (ASGN) has an interest coverage ratio of 3.4x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Asgn Inc?

Asgn Inc (ASGN) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.